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Tbjective: Division of secondary chords (chordal cutting) has been proposed as a
ethod for decreasing mitral valve leaflet tethering and mitral regurgitation in
atients with ischemic mitral regurgitation. However, very little clinical data exist to
ate for this procedure.
ethods: We compared echocardiographic and clinical data in patients who under-
ent chordal-cutting mitral valve repair (n  43) and those undergoing conven-
ional mitral valve repair (control, n  49) for ischemic mitral regurgitation.
esults: Patients who underwent chordal cutting had a higher prevalence of recent
yocardial infarction, left main disease, diabetes, and peripheral vascular disease
all P  .05). Left ventricular ejection fraction was lower in the chordal-cutting
roup (33 2% vs 44 2%) (mean SE) and preoperative tent height was greater
11.7  0.5 vs 9.7  0.6 mm; both P  .01). In-hospital mortality was 10% in
ontrol patients and 9% in the chordal-cutting group (P  .9). Other complication
ates were similar for the two groups. The reduction in tent height before-to-after
epair was similar in the two groups of patients, but those undergoing chordal
utting had a greater reductions in tent area (53  3% vs 41  3%; P  .01). The
hordal-cutting group also had greater mobility of the anterior leaflet, as measured
y a reduction in the distance between the free edge of the anterior mitral valve
eaflet and the posterior left ventricular wall (24  3% vs 11  4%; P  .01).
ontrol patients had more recurrent mitral regurgitation during 2 years of follow-up
y univariate (37% vs 15%; P  .03) and multivariate analysis (P  .03). Chordal
utting did not adversely affect postoperative left ventricular ejection fraction (10%
5% relative increase in left ventricular ejection fraction vs 11%  6% in the
ontrol group; P  .9).
onclusion: Chordal cutting improves mitral valve leaflet mobility and reduces
itral regurgitation recurrence in patients with ischemic mitral regurgitation, with-
ut any obvious deleterious effects on left ventricular function.
schemic mitral regurgitation (IMR) is always preceded by a myocardial infarction
(MI) and is an important cause of cardiac morbidity and mortality after MI. IMR can
be classified as acute or chronic, according to the time of presentation. Chronic IMR
s a much more common clinical entity and is the focus of the current article.
Chronic IMR is defined as mitral regurgitation (MR) occurring greater than 1
eek after MI with (1) one or more left ventricular (LV) segmental wall motion
bnormalities, (2) significant coronary disease in the territory supplying the wall
otion abnormality, and (3) structurally normal mitral valve (MV) leaflets and
hordae tendineae.1 IMR is an important cause of congestive heart failure a
ssociated with worse long-term survival after MI.2-4 The prevalence of chroni
MR may be increasing with time, as a higher proportion of patients survive acuteI. It has been estimated that 1.2 to 2.8 million Americans currently have IMR. 1,5
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1
A
CDThe most common operation performed for chronic I
s undersized mitral annuloplasty, as popularized by Bol
nd colleagues.6,7 Although undersized mitral annuloplast
an be performed with acceptable rates of morbidity 
ortality, several investigators have questioned its dura
ty. McGee and colleagues8 demonstrated that recurrent M
moderate-to-severe or severe) develops in 30% of pati
 year after undersized annuloplasty, a finding that has 
onfirmed by others.9-11 In addition, undersized annulo-
lasty does not improve long-term survival in patients 
hronic IMR.12 Such findings have led investigators 
xamine alternative methods of surgical treatment for IM
Recent advancements in the understanding of chro
MR pathophysiology have led to new approaches in 
py.1,13 It is now widely accepted that the predomin
ause of chronic IMR is apical displacement and tethe
f the MV leaflets, preventing central coaptation du
ystole. Infarcted myocardium (predominantly in the p
eroinferior territory) displaces the MV leaflets apically 
utwardly and decreases ventricular force required to c
he leaflets.14 The mitral annulus may dilate and theref
ontribute to the regurgitation, but IMR can occur w
ormal-sized annulus.
Such insights recently led to a novel surgical appr
or chronic IMR. Messas, Levine, and colleagues15,16 dem-
nstrated that division of MV secondary chords (the “ch
l-cutting” procedure) results in decreased leaflet tether
nd decreased mitral insufficiency in a sheep model of 
econdary chords attach to the belly of the MV leaflet
ause kinking of the anterior leaflet in patients with 
esulting in the “seagull sign” on echocardiography.1 The
hordal-cutting procedure may relieve leaflet tethering, 
mportant cause of recurrent mitral insufficiency after 
epair.11 The operation has been described in case -
orts,17,18 but clinical experience is very limited to date.
erein describe our early results in a group of pa
ndergoing the chordal-cutting operation and compare 
linical and echocardiographic outcomes with those of 
ients undergoing conventional MV repair for IMR.
atients and Methods
thics approval for this study was granted by our institut
esearch ethics board. Our computerized database was examine
Abbreviations and Acronyms
IMR ischemic mitral regurgitation
LV  left ventricular
MI myocardial infarction
MR mitral regurgitation
MV mitral valve
TEE  transesophageal echocardiographydentify all patients undergoing MV repair for IMR from Januaryw
484 The Journal of Thoracic and Cardiovascular Surgery ● Jun.
d
,
s
, 1998, to December 31, 2005. We excluded patients underg
V replacement for IMR, as well as patients undergoing con
tant LV aneurysmectomy. Preoperative echocardiograms and 
rative reports were reviewed to confirm that the MV disease
schemic in nature and to determine what type of surgical p
ure was performed. Patients were divided into two groups
ording to operative technique: those undergoing conventio
ndersized mitral annuloplasty (control, n  49) and those unde
oing the chordal-cutting operation (n  43).
Follow-up was obtained by telephone and mail questionnair
atients or family members, or both, between January 1 
ebruary 28, 2006. The first chordal-cutting operation was 
ormed at our institution in May 2003. Some surgeons adopte
echnique over the following 2 years whereas others continue
erform undersized mitral annuloplasty during the entire st
eriod. Because the length of follow-up was longer in
ontrol group, we truncated follow-up in all patients to 2 
ostoperatively.
urgical Technique
ndications for MV repair were symptoms of heart failure (
ork Heart Association class II or greater) and moderate or 
ie, 2 or more) MR on preoperative echocardiography, althou
ome patients with 1 MR also underwent MV repair. Intraop
tive transesophageal echocardiography (TEE) was used to c
rm the pathologic condition (ie, leaflet tethering) but no
etermine whether or not MV repair was indicated.
A left atriotomy was performed posterior to the intera
roove and the MV was thoroughly inspected to rule out no
mic pathologic abnormalities. Interrupted 2-0 braided sutu
ithout pledgets were placed along the posterior annulus from
edial to lateral fibrous trigones. A flexible incomplete ann
lasty band (Cosgrove–Edwards annuloplasty system; Edwar
ifeSciences, Irvine, Calif) was inserted in both groups of pat
he annuloplasty band was moderately undersized in all pat
nd ranged from size 26 to 32, depending on the patient’s
urface area.
In the chordal-cutting group, we divided secondary chord
he anterior leaflet, posterior leaflet, and the commissure that 
rom the papillary muscle or muscles affected by the infarcted
yocardium. Secondary chords arising from normal papillary
uscles were not divided. The affected papillary muscle was
dentified by preoperative echocardiography or ventriculography
r both. Secondary chordal cutting was performed before insertion
f the annuloplasty band to optimize exposure. Secondary chords
ere carefully separated out from primary chords with a nerve
ook, confirming their attachment to the belly of the leaflets rather
han to the free edge. All secondary chords from the affected
apillary muscle(s) that could be identified were divided.
chocardiography
ransthoracic echocardiography was performed preoperatively,
efore discharge, and during the most recent follow-up in patients.
R grade was quantified as none or trivial (0), mild (1), mod-
rate (2), moderate-to-severe (3), or severe (4) on the basis
f color jet area and shape, pulsed wave Doppler of pulmonary
eins, and proximal isovelocity surface area.19 LV ejection fraction
as calculated by the modified Simpson and Quinones method. 20
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A
CDIntraoperative TEE was used to measure several variables
ore and after MV repair in a subset of patients. Measure
ere performed by a single echocardiographer (P.M.), who 
linded to patient group assignment. All measurements were
ained via the mid-esophageal 120° view, with the exceptio
ent height and area, which were obtained in the apical 4-cha
iew. The measured variables were (1) mitral annulus diam
2) tent height (distance from the leaflet coaptation point t
itral annulus), (3) tent area (area formed by the triangle be
nnular plane and the apex of the leaflet coaptation point in
entricle during systole), and (4) anterior MV leaflet–posterior
entricle (distance between the free edge of the anterior MV 
nd the posterior LV wall as a measure of anterior leaflet mo
easurements were obtained during two different cardiac cy
nd the average value was recorded. None of the patients had
brillation during measurement acquisition.
tatistical Analysis
ategorical variables are expressed as percentages and continu
ariables are expressed as mean  standard deviation throughou
he manuscript, with the exception of echocardiographic d
hich are expressed as mean  standard error. All statistica
nalyses were performed with the SAS system (SAS version
AS Institute, Inc, Cary, NC). Categorical variables were c
ared with 2 or Fisher exact tests, and continuous variables w
ompared with unpaired t or Wilcoxon tests. Stepwise multiva
ble logistic regression analysis was used to determine the 
endent predictors of recurrent MR. Survival and event-free 
ival were analyzed with the methods of Kaplan and M
nivariately and Cox regression multivariately.
esults
reoperative characteristics for the two groups of pati
re displayed in Table 1. Patients in the chordal-cu
roup had significantly worse LV function than did co
atients, as well as significantly larger LV diameters du
ystole. The chordal-cutting group was also more likel
ave a history of MI within 30 days of surgery, left
oronary disease, diabetes mellitus, and peripheral vascu
isease.
Intraoperative characteristics for the two groups of 
ients are displayed in Table 2. There were no signifi
ifferences for any of the listed variables, with the exce
f a higher prevalence of left internal thoracic artery u
n the chordal-cutting group. Table 3 displays the e
ostoperative clinical outcomes for the two groups of pa-
ients. There were no significant differences for any of the
ariables listed with the exception of a higher prevalence of
trial fibrillation in the chordal-cutting group. In-hospital
ortality was 10% in the isolated annuloplasty group and
% in the chordal-cutting group (P  .9).
chocardiographic Data
ransthoracic echocardiography was performed in all pa-ients preoperatively and in all surviving patients postoper- i
The Journal of Thoracics
r
e
e
t
).
l
in
t
tively. The prevalence of preoperative central, eccentric,
nd complex MR jets is displayed in Table 1.
Detailed measurements were obtained from intraopera-
ive TEE in 82% of patients (n  75). The intraoperative
EE digital tape was irretrievable in 12 patients or had
nadequate images in 3 patients, whereas 2 patients had a
ontraindication to TEE examination. As can be seen in
able 4, the tent height (distance between the coapta
oint of the MV leaflets and the mitral annulus) was signif-
ABLE 1. Preoperative characteristics for patients under-
oing isolated mitral annuloplasty (control) or division of
econdary chords plus annuloplasty (chordal cutting) for
MR
ariable
Control
(n  49)
Chordal cutting
(n  43) P value
R grade .14
1–2 29% 43%
3–4 71% 57%
irection of MR jet*
Central 55% 49% .5
Eccentric 20% 28% .4
Complex 28% 35% .5
V ejection fraction 44%  15% 33%  11% .001
V diastolic diameter (mm) 53  8 56  10 .10
V systolic diameter (mm) 40  8 45  11 .02
ge (y) 63  8 66  8 .09
ody surface area (m2) 1.9  0.2 1.8  0.2 .12
emale sex 29% 38% .3
ecent MI 15% 33% .04
ongestive heart failure 71% 87% .07
YHA class IV 47% 64% .08
edo CABG 10% 5% .3
nstable angina 16% 24% .2
eft main disease 12% 28% .05
OPD 2% 0% .6
moking history 73% 62% .5
rgent timing 39% 59% .06
reop stroke/TIA 6% 15% .14
ypertension 67% 69% .9
yperlipidemia 63% 72% .4
enal failure 4% 3% .8
iabetes mellitus 31% 51% .04
eripheral vascular
disease
12% 33% .01
ortic valve disease 6% 9% .4
ricuspid valve diseae 8% 8% .9
ontinuous variables are expressed as mean  standard deviation. IMR,
schemic mitral regurgitation; MR, mitral regurgitation; LV, left ventricle;
I, myocardial infarction; NYHA, New York Heart Association classifica-
ion; CABG, coronary artery bypass grafting; COPD, chronic obstructive
ulmonary disease; TIA, transient ischemic attack. *Eccentric mitral re-
urgitation jet refers to posterolateral or anterolateral direction; complex
et refers to an eccentric jet or multiple jets.cantly greater in the chordal-cutting group before MV
and Cardiovascular Surgery ● Volume 133, Number 6 1485
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Surgery for Acquired Cardiovascular Disease Borger et al
1
A
CDepair. Chordal cutting resulted in a significantly increa
eduction in the tent area after MV repair (the area be
he mitral annulus and the coaptation point of the leafl
s well as increased reduction in the distance between
ree edge of the anterior MV leaflet and the posterio
all.
The change in MR on transthoracic echocardiograp
rom before to after the operation in patients who surv
he perioperative period is displayed in Figure 1. The 
ge grade of MR was similar between groups preop
ABLE 2. Intraoperative characteristics for the two groups
f patients
ariable
Control
(n  49)
Chordal cutting
(n  43) P value
ize of MV band .4
26 10% 9%
28 31% 40%
30 45% 40%
32 14% 11%
oronary bypass grafting 92% 92% .9
se of LITA 43% 64% .04
ortic valve surgery .4
Replacement 6% 7%
Repair 0% 2%
ricuspid valve surgery .6
Replacement 6% 0%
Repair 2% 8%
aze procedure 2% 2% .9
rossclamp time (min) 93  23 107  25 .5
PB time (min) 119  33 131  28 .3
ontinuous variables are expressed as mean  standard deviation. MV,
itral valve; LITA, left internal thoracic artery; CPB, cardiopulmonary
ypass.
ABLE 3. Postoperative outcomes for the two groups of
atients
ariable
Control
(n  49)
Chordal cutting
(n  43) P value
yocardial infarction 2% 0% .6
ow cardiac output syndrome 8% 15% .3
troke 2% 5% .4
eoperation for bleeding 6% 5% .9
enal failure 2% 5% .4
trial fibrillation 22% 44% .03
acemaker 16% 23% .4
ortality 10% 9% .9
entilation time (h) 37  80 61  164 .1
CU stay (d) 4.6  5.5 5.0  7.7 .3
ospital stay (d) 11  6 12  9 .5
ontinuous variables are expressed as mean  standard deviation. ICU,
tntensive care unit.
486 The Journal of Thoracic and Cardiovascular Surgery ● Junn
,
-
ively, but it was significantly lower in the chordal-cu
roup postoperatively.
The most recent echocardiogram (truncated at 2 y
ostoperatively in the control group) revealed moderate
ore MR (ie, 2 or greater) in 15% of surviving patie
aving the chordal-cutting procedure and 37% of con
atients (P  .04). Logistic regression analysis revealed th
he type of operation was the only independent predict
ecurrent MR (odds ratio 3.9 for undersized annulopla
  .03).
As noted earlier, LV function was significantly wors
he chordal-cutting group preoperatively. The change in 
jection fraction from the preoperative to the follow
eriod was similar in the two groups of patients: 10
8% relative (not absolute) increase in the chordal-cutting
roup versus 11%  39% in the control group (P  .9).
linical Outcomes During Follow-up
urvival 2 years postoperatively was 82%  6% in the
ontrol group and 79%  9% in the chordal-cutting group
P  .8, Figure E1). The causes of death during follow
n the chordal-cutting group were complications of periop-
rative stroke in 1 patient and hemolysis and end-stage renal
ailure in 1 patient. In the control group, the causes of death
uring follow-up were congestive heart failure, renal fail-
re, and thoracic aneurysm surgery (1 patient each). Cox
egression failed to reveal any independent predictors of
ong-term survival.
Figure E2 displays the event-free survival for the two
roups, defined as freedom from death, recurrent moderate
r more MR (2 or greater), reoperation, thromboembo-
ism, hemolysis, major hemorrhage, or endocarditis. Throm-
oembolism occurred in 1 patient in each group during
ollow-up, hemolysis occurred in 1 patient in each group,
ndocarditis occurred in 1 control patient, and major hem-
rrhage did not occur in any patient. A total of 5 patients in
ABLE 4. Intraoperative transesophageal echocardio-
raphic measurements
ariable
Control
(n  39)
Chordal cutting
(n  36) P value
itral annular diameter (mm) 34 1 35  1 .3
ent area (cm2) 2.5  0.2 2.9 0.2 .14
MVL–posterior LV (mm) 24 9 21  6 .2
rerepair to postrepair
reduction
Mitral annulus 28% 3% 33% 2% .2
Tent height 20% 3% 24% 4% .4
Tent area 41% 3% 53% 3% .01
AMVL–posterior LV 11% 4% 24% 3% .01
ontinuous variables are expressed as mean  standard error. AMVL,
nterior mitral valve leaflet; LV, left ventricle.he control group underwent reoperative MV replacement in
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A
CDhe first 2 years postoperatively: 3 patients for recurrent 
 for hemolysis and recurrent MR, and 1 for endocardit
ontrast, none of the patients in the chordal-cutting g
nderwent reoperation. However, recurrent MR develop
 months postoperatively as a result of dehiscence o
nnuloplasty ring in 1 patient in the chordal-cutting gr
he patient had severe hemolysis and renal failure but
urned down for reoperation because of multiple comorb
ies. The patient died 11 months postoperatively.
Event-free survival was 52%  7% in the control grou
nd 70%  9% in the chordal-cutting group 2 years p
peratively (P  .2, Figure E2). Cox regression reveal
hat eccentric MR was the only independent predicto
ecreased event-free survival (hazard ratio 3.4; P  .02).
iscussion
MR is a consequence of MI. The hallmark of IMR is mitral
nsufficiency in the face of structurally normal MV leaflets
nd chords. The predominant cause of IMR is apical dis-
lacement and tethering of the MV leaflets, with subsequent
ecreased coaptation. Infarcted myocardium results in dis-
lacement of the affected papillary muscle during systole, as
ell as decreased closing forces on the leaflets.13,14 Mitral
nnular dilation may also occur and can lead to increased
nsufficiency, but annular dilation is not essential for the
evelopment of IMR.
MV repair results in better survival than MV replace-
ent in patients with IMR, except in high-risk patients, in
hom survival is similar for the two techniques.21,22 The
ost commonly performed surgical procedure for IMR is
solated undersized annuloplasty. Isolated annuloplasty is
eproducible and can be performed with acceptable rates of
orbidity and mortality, even in high-risk patients.6,7 How-ver, undersized annuloplasty does not significantly im- fi
The Journal of Thoracic,
n
s
rove long-term survival when compared with medical
anagement.12 Several investigators have described a hi
ate of MR recurrence, approximately 30%, after undersized
solated annuloplasty for IMR.8-11 Such findings have le
nvestigators to examine a host of other surgical options,
ncluding the edge-to-edge (Alfieri) repair, infarct plication,
apillary muscle imbrication, papillary muscle “sling,” sur-
ical relocation of the posteromedial papillary muscle, and
osterior MV restoration.1 The amount of clinical expe-
nce with each of these techniques is very limited.
Messas, Levine, and associates15,16 proposed division o
he secondary chords as a method of improving leaflet
obility and decreasing leaflet tethering for chronic IMR.
econdary chords result in kinking of the anterior MV
eaflet in chronic IMR but are not required to prevent leaflet
rolapse. Messas and colleagues demonstrated that dividing
econdary chords in a sheep model of acute15 and chronic16
MR resulted in improved leaflet coaptation and reduced
R, without leaflet prolapse or decline in LV ejection
raction. The chordal-cutting operation is intended to pre-
ent persistent leaflet tethering after MV repair, an impor-
ant cause of recurrent IMR.11 It has been described in a f
ase reports in humans,17,18 but clinical experience is ve
imited.
We started performing the chordal-cutting operation in
003 and have been performing this procedure in an in-
reasing number of patients over time. The current article
escribes our early results with this group of patients and
ompares them with a group that underwent isolated under-
ized annuloplasty. The chordal-cutting group had an in-
reased prevalence of several preoperative risk factors, in-
luding worse LV function, than the control group. This
Figure 1. Grade of MR preoperatively
and during follow-up in the control
group (left) and the chordal-cutting
group (right). Both groups showed a
significant reduction in the grade of
MR from before to after surgery (P <
.001). Preoperative MR grade was sim-
ilar between groups, but postoperative
MR grade was lower in the chordal-
cutting group (P  .04). MR, mitral
regurgitation.nding probably reflects our increased comfort level with
and Cardiovascular Surgery ● Volume 133, Number 6 1487
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1
A
CDhe chordal-cutting procedure and our willingness to 
orm this operation in higher-risk patients.
We used a flexible, incomplete annuloplasty band fo
atients in the current study. Several articles in the liter
ave discussed the optimal annuloplasty device for pati
ith chronic IMR, with conflicting results. Although m
urgeons prefer a complete ring,23 we use an incomplet
and because we do not believe dilation of the intertrig
istance plays a major role in the pathogenesis of IMR24 In
he current study, the mitral annulus measured 3.4  0.1
m in all patients (Table 4), which is within the ran
ormal values.25 Although it can be argued that our res
ay have improved with the use of a complete, rigid
t is important to stress that both groups of patients rec
he same annuloplasty device and therefore a compariso
he two groups should yield a valid estimate of the eff
hordal cutting.
The predominant concern for the chordal-cutting ope
ion has been possible deleterious effects on LV func
odriguez and colleagues26 used an acute IMR sheep mod
o demonstrate that division of the anterior leaflet secon
hords results in decreased LV function. These investiga
emonstrated decreases in end-systolic elastance and p
oad recruitable stroke work, as well as increased transm
train and altered LV geometry, after anterior leaflet cho
utting in acutely ischemic sheep. These same investiga
lso demonstrated that chordal cutting had no benefi
ffect on mitral insufficiency in an acute sheep mode
MR.27 These findings are in contrast to the studies
essas and associates,16 which demonstrated reduced M
nd no decrease in LV ejection fraction at a mean per
3 weeks after chordal cutting in a chronic ischemia m
 recent publication by the same investigators demonstr
reservation of LV volumes, ejection fraction, systolic v
ricular elastance, preload-recruitable stroke work, and 
ate of pressure rise after secondary chordal cutting.28 One
xplanation for these discrepant findings is that acute 
mia models are more likely to show decreases in
unction because the papillary muscles and surround
yocardium are normal. In contrast, models of chro
schemia are more representative of the clinical situatio
hich papillary muscles and surrounding myocardium 
nfarcted and scarred. Cutting secondary chords that a
nly from infarcted myocardium, as done in the cu
tudy, may not be as deleterious as cutting chords 
ormal, healthy myocardium.
We failed to demonstrate any significant echocard
raphic decrease in LV function after chordal cutting in
urrent study, a finding that can be supported by se
ines of evidence. First, there was no significant increa
notrope usage or low cardiac output syndrome in the cho
utting group, despite the fact that this group had wors
unction than control patients. Second, operative mortality w
488 The Journal of Thoracic and Cardiovascular Surgery ● Junl
of
,
d
of
f
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.
l
-
as similar for the two groups, despite a higher preva
f several risk factors in the chordal-cutting group. 
erioperative mortality rate for the chordal-cutting gro
9%) was similar to that achieved in large series of
epair for IMR (approximately 10%).21,29 Third, division o
econdary chords has been performed for more than
ears during MV repair for myxomatous disease (du
liding annuloplasty and chordal transfer procedures) w
xcellent long-term results and no obvious deleterious 
ects on patient survival or symptoms.30 We therefore be-
ieve that chordal cutting does not adversely affect 
unction in patients with chronic IMR.
In the current study, recurrent moderate or more MR
bserved in 37% of the isolated annuloplasty group. O
nvestigators have achieved better results after MV re
or IMR, particularly Braun and associates.31 These inves-
igators had an 8% rate of MR recurrence 18 months 
peratively. One possible explanation for their better res
s that these investigators used a complete, rigid ring 
ore aggressive undersizing. However, we should o
gain stress that both groups of patients in our stud
eived the same size and type of annuloplasty device
herefore the incremental effect of chordal cutting shoul
alid. Although the MR recurrence rate in our control g
s relatively high, it is well within the quoted range 
iterature.8-11
The mechanism of recurrent MR after isolated ann
lasty is likely related to persistent leaflet tethering.11 Di-
ision of secondary chords was associated with a decre
ecurrence rate of MR in the current study by univariat
ultivariate analysis. The decreased recurrence rate w
articularly noteworthy given that patients in the chor
utting group had increased MV leaflet tenting preop
ively (Tables 1 and 4), a risk factor for recurrent MR11,32
Chordal cutting may reduce MR by increasing lea
obility and decreasing leaflet tethering.15,16 In the curren
tudy, patients subjected to chordal cutting had decreased
V tent height and tent area after MV repair. They also had
decreased distance between leaflet coaptation and the
osterior LV wall, suggestive of increased mobility of the
nterior leaflet. Other investigators have demonstrated in-
reased anterior leaflet mobility and concave curvature after
ivision of the secondary chords.33,34 Despite our positiv
ndings, recurrent MR still occurred in 15% of the chordal-
utting group. We can infer that chordal cutting represents
n incremental improvement over isolated annuloplasty for
urgical treatment of IMR, but it is not the final answer for
his vexing clinical problem.
tudy Limitations
he main limitation of the current study is its retrospective
nd nonrandomized design. A randomized clinical trial
ould be the most appropriate method of comparing
e 2007
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CDhordal cutting with undersized annuloplasty for IM
owever, MV repair for IMR is an uncommon sur
rocedure, despite the large number of patients with 
isorder, and therefore a randomized trial is unlikely t
erformed in the near future. Since chordal cutting is
ently being performed in several centers around the w
he current study represents the best available data on
ew procedure.
Another limitation of the current study is our metho
ssessing postoperative LV function. We used transthora
chocardiography, which is load-dependent. Although 
linical tests of LV function are load-dependent to a ce
xtent, rest and exercise nuclear angiography may b
etter measure of LV function and may be preferable
uture studies.
Another possible limitation is that patients in the cho
utting group had a higher prevalence of recent MI a
igher percentage of left internal thoracic artery us
hich may have led to better reverse remodeling and
R postoperatively. However, type of operation perform
as the only independent predictor of recurrent MR in
ultivariable analysis, even after adjusting for preoperat
I and left internal thoracic artery usage.
The final limitation of our study is the relatively 
eriod of follow-up. It is possible that chordal cutting 
s durable as undersized annuloplasty for IMR, but 
ime will tell. However, the current study included up
ears of follow-up, and most cases of MR recur withi
rst year after MV repair for IMR.8
onclusions
e compared clinical and echocardiographic outcomes
atients undergoing the chordal-cutting procedure w
hose undergoing undersized annuloplasty. Although t
hordal-cutting group had an increased risk profile, inc
ng worse LV function and more mitral leaflet ten
erioperative outcomes were similar. Chordal cutting 
ulted in decreased leaflet tenting, increased leaflet mobi
nd decreased recurrence of MR during follow-up. We
onclude that chordal cutting represents a safe, increme
mprovement over undersized annuloplasty for the treat-
ent of IMR. However, further refinements are probably
ecessary before we can claim success in the surgical treat-
ent of this difficult clinical problem.
We acknowledge the help of Joan Ivanov, PhD, with statistical
nalyses.
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iscussion
r D. Craig Miller (Stanford, Calif). Thank you, Dr Borger. That
as a nice presentation. I don’t want anyone in this room to run home
nd try this, however. Despite how great it looks on the surface, it
ooks too good to be true and probably is too good to be true.
Let me reframe the controversy for the audience. Robert Levine’s
GH group has shown in acute and chronic sheep models of IMR
hat if you cut the second-order chords there is more leaflet area for
oaptation and the valve is more competent. My concern has always
een what cost do you pay in terms of ventricular systolic function
hen you cut the second-order chordae? Indeed, it is ironic that the
enior author on this paper is the very one and same Tirone E. David
ho first convincingly demonstrated in a canine experimental prep-
ration 23 years ago that cutting the chordae tendineae was bad for left
entricular systolic function. Further, these are sick ventricles. To
araphrase the Gorman brothers: IMR is not a valvular disease, it’s a
entricular disease, and these are sick ventricles crying out for help. If
e impair their LV contractile performance more, we actually may be
arming patients even if there is less postoperative recurrent IMR.
Congratulations for proving in the first sizable clinical series that
utting second-order chordae is feasible and safe with no apparent
arly side effects. I remain unconvinced, however, that the putative
echanism responsible for less recurrent MR was actually due to c
490 The Journal of Thoracic and Cardiovascular Surgery ● Junhat you did. I also am skeptical that you actually did not impair left
entricular systolic function by cutting the chords.
Why am I unconvinced? First, you do not have the proper con-
urrent control group -- similar patients with IMR undergoing CABG
lone -- but none of us do. A prospective controlled trial where
ne-half of your IMR patients was randomized to chordal division
ould be ideal, but we do not live in a utopia. More practically
peaking, you have not analyzed all the intra-operative and postoper-
tive echo data available to you, which is where you have let us and
ourselves down.
You showed us intraoperative TEE data for just the first 20
atients in each group. Why didn’t you analyze the echo data for all
2 patients? Further, you focused exclusively on type III-b leaflet
otion (restricted systolic leaflet closure). IMR is often a combination
f septal-lateral (S-L) annular dilatation (type I or normal leaflet
otion with IMLC) and type III-b leaflet motion. You didn’t even tell
s what kind of moderate IMR leaks you were treating. Were these
ccentric complex MR jets (type III-B) or central straight back jets
type I), or both mechanisms, as we frequently see?
As an editorial comment, I think you have used the completely
rong type of ring for these IMR patients. A Cosgrove band is great
or prolapse, but I think most of us now believe IMR is best treated by
complete, very rigid ring which by design disproportionately down-
izes the AP or S-L annular axis.
Let’s get back to the echo information. I was disappointed that you
resented quantitative intraoperative TEE data for only 20 patients in
ach group. Indeed, you could not even prove statistically that cutting
he second-order chordae reduced tenting area or height compared to
he more conventional ring only group based on these numbers.
aybe analysis of larger numbers of patients would have allowed you
o substantiate your the conclusion and prove that the reduced inci-
ence of postoperative IMR was due to less apical tethering, a direct
ffect of cutting the second-order chordae. Further, for the 2 year
ostoperative transthoracic echocardiograms you don’t give us any
nformation aside from how many patients had moderate or worse
ecurrent IMR. What about mitral S-L annular dimension, tenting
rea, tenting height and all the LV dimensions and geometry for all
urvivors in both groups, and specifically for those with recurrent
MR? Was there more salutary reverse LV remodeling over time in
he chordal-cutting group? I applaud you for demonstrating a major
eduction in postoperative residual/recurrent IMR in the chordal di-
ision group, but we need to know why this happened on a mecha-
istic basis. I’m just not sure that cutting the second-order chordae
ruly explains these favorable results. Many things were changing
ver time, the patient cohorts were dissimilar, and these two technical
pproaches were applied sequentially and not concurrently.
Concerning LV systolic function, as you and I have discussed
arlier, the audience should be circumspect in that you did perform
ny rest and exercise echo or radionuclear stress testing to assess LV
ontractile reserve. Just looking at changes in resting echo EF is not
ery persuasive.
In the event-free survival curves which clearly favored the chord-
l-cutting technique, perhaps you may have been a little bit mislead-
ng. You excluded recurrent IMR as part of this composite clinical
nd-point. There was one patient in the chordal-cutting group who
ad severe recurrent MR but was deemed inoperable and therefore not
eoperated on. This important complication is missing from these
urves. Better yet, if you would have included all events, including
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CDecurrent MR, I think you have enough adverse events in a large
nough population that these data could have been subjected to what
he Toronto group has regularly done in their clinical research efforts,
hat is, test your hypothesis using a rigorous multivariable Cox model
ith bootstrapping, ideally including propensity score analysis (if you
ad enough patients to unbalance the numbers in order to balance the
isk of adverse outcome). Some of the independent variables to be
ntered would include all the clinical descriptors, operative year,
urgeon identifier, chordal-cutting technique or not, annuloplasty band
ize, and interval between last MI to operation. This type of compre-
ensive statistical approach is the only robust way to demonstrate
rom your retrospective data whether or not dividing the second-order
hords is more effective than your conventional repair method. Let us
ot forget that patient selection biases and surgeon bias are ubiqui-
ous!
I thank you, Mike, and your colleagues for this important work
nd demonstrating it is safe and feasible to cut the second-order
hordae during mitral valve repair for patients with IMR. I only wish
ll the data had been analyzed and the statistical approach had been
ore rigorous.
Dr. Borger: Thank you, Dr. Miller. Trying to defend a paper on
schemic mitral regurgitation to you is a little bit like trying to defend
paper on the theory of relativity to Einstein. But I will try.
First of all, your comments about how our philosophy has changed
rom preaching that we have to retain chords to now saying that we
an sacrifice them, there is a bit of a subtle difference there. The
riginal studies that said that we should retain continuity between the
nnulus and the papillary muscles when you replace the mitral valve,
hey did not make a distinction between primary and secondary
hords. What we are proposing now is cutting the secondary chords
nly. The primary chords remain intact and therefore there is conti-
uity of the papillary muscle-annular mechanism.
Why did we not obtain detailed intraoperative echo data on all of
he patients? My only response is that these measurements are ex-
remely time-consuming to perform. All of these measurements were
btained during off-line analysis of two different cardiac cycles,
hich takes a lot of time. In addition, we felt that the more important
linical outcome was recurrent mitral regurgitation on postoperative
ransthoracic echo rather than intraoperative TEE measurments. But
ou’ve raised a valid point and I will have to go back and queue up
hose tapes and get some more data on the remaining patients.
Regarding your question on the mechanism of the mitral regurgi-
ation, it was a typical ischemic MR leak with a combined eccentric
et and central component in the majority of patients. It is not our
bservation that ischemic MR is due mostly to annular dilatation. We
elieve that annular dilatation plays a relatively minor role in ischemic
R. When you look at our data, the average mitral annulus diameter
n both groups was only 3.4 cm, which is at the upper end of normal.
he data on the type of regurgitant jet is currently missing from the
aper, but I do have it and I will insert it.
It has been our institutional philosophy for many years that we use
partial incomplete flexible ring for ischemic MR. I am very familiar
ith the literature for ischemic mitral regurgitation, I know there are
lot of proponents of a complete rigid ring. However, I do not believe
t has been conclusively shown that a complete rigid ring is absolutely
equired. I think that it is still in the stage of equipoise, and hopefully
ver time somebody will be able to definitively determine the optimal a
The Journal of Thoracicing type. For now we are using partial incomplete rings, but a couple
f years from now we may be switching to a complete rigid ring. .
As far as left ventricular function goes, we used postoperative
ransthoracic echocardiography and this is probably not the best
ethod. Radionuclide angiography is probably a better method. How-
ver, these tests are not part of our standard postoperative clinical
ollow-up evaluation. Regardless, we feel there is a lot of evidence
uggesting that we did not adversely affected left ventricular function.
espite the chordal-cutting group having a 10% lower ejection frac-
ion, and that was an absolute 10% difference and not a relative 10%,
hese patients had no increase rate of inotrope usage, low cardiac
utput syndrome, and or mortality when compared to the undersized
nnuloplasty group. So we feel comfortable with this operation and
e do not think that it results in any obvious decrement in left
entricular function.
And then finally to address your point about our definition of
vent-free survival. We used a definition based on the currently
ccepted norms for valve surgery reporting, and those norms usually
o not include recurrent MR without reoperation. Certainly we can
dd recurrent MR, to the event-free survival curves. But thisshould
esult in an even more favorable picture of the chordal-cutting group,
ecause there were only two patients in the chordal-cutting group that
eveloped severe mitral regurgitation versus five in the undersized
nnuloplasty group. It is true that we did not reoperate on the two
hordal-cutting patients who developed recurrent MR because they
ere very sick. However, four of the five undersized annuloplasty
atients who developed recurrent MR underwent mitral valve replace-
ent.
Dr. C. Duran (Missoula, MT):
One, we have to congratulate the authors for reporting on the only
argest series with this intriguing very simple and, in my opinion,
angerous operation. I was also surprised, like Dr. Miller, that the
enter that has defended so clearly and as pioneers of this continuity
etween the papillary muscle and the annulus, now you recommend
utting the basal chords. You say they are different from the marginal
hords. They certainly are very different in terms that they are four
imes the thickness of the marginal ones and they sustain stress during
he whole cardiac cycle; they are taut during the whole cardiac cycle.
o those very impressive chords when you look from the ventricle, to
ust cut them happily and hope that nothing happens I think is a bit
remature.
We did repeat the studies, following closely the studies of the
tanford group, and in our case we cut the two medial anterior basal
hords, that is, from both halves of the anterior leaflet, and the results
mmediately, those were acute experiments, there was a drop in stroke
olume, dP/dt, increasing length between the apex and the annulus,
nd a reduction in the aortomitral angle. So they were all negative
ositions.
So my question is, why the difference, why your results are very
ood and the animal ones are very bad? Secondly, is that because in
he animals we didn’t do an annuloplasty and maybe the annuloplasty
rotects cutting those chords, or is it that we were cutting different
hords than you were? And certainly from your presentation I get the
dea that you cut the one from the A2 and commissure and the
osterior leaflet at the level of B3. I don’t know which, what expla-
ation.
But before finishing, just a warning to people. The danger is it is
simple operation, but they just walk home and they say I am going
and Cardiovascular Surgery ● Volume 133, Number 6 1491
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CDo have a series of this new technique, and I think it would be
remature. I think it is good for you to continue and to report what the
ong-term results are.
Thank you very much.
Dr. Borger: Thank you, Dr. Duran. I can see I am not gaining any
riends with this operation. I want to stress one point. We are not
rying to say that the chordal-cutting procedure is a panacea for
schemic mitral regurgitation. We have not found the cure for isch-
mic mitral regurgitation, by any means. I agree wholeheartedly with
r. Miller and Dr. Gorman that this is a very vexing clinical problem
nd we don’t have the answers yet, and surgery may not even be the
est option for many of these patients. However, often you have
atients that are hospitalized with congestive heart failure and surgery
s the only potential life raft that they have.
Regarding the differences between our observations and the del-492 The Journal of Thoracic and Cardiovascular Surgery ● Junmportant to note that the animal models involve acute ischemic
njury to normal ventricles. They are not chronic long-term ischemic
entricles like we see in patients. I believe that we should repeat the
nimal model work using hearts that have been ischemic for at least
ight weeks before we definitively state that there are deleterious
ffects for this operation. It is also important to note that we have been
ividing secondary chords during mitral valve repair for myxomatous
isease for approximately 25 years, during the sliding annuloplasty
rocedure, without any obvious detrimental effects on left ventricular
unction.
And once again, I have to stress that we are not saying that we
ave found a cure for ischemic MR. We simply feel we have found
more effective method of decreasing the amount of residual and
ecurrent mitral regurgitation than the undersized annuloplasty pro-
edure. As we continue to follow our patients, we hope to have someterious effects of cutting secondary chords in animal models, it is more answers for you over the next few years.
JTCVS On-Line Manuscript Submission and Review
The Journal of Thoracic and Cardiovascular Surgery requires authors and reviewers to
submit all new and revised manuscripts and reviews via Editorial Manager. Point your
browser to http://jtcvs.editorialmanager.com, log in as author or reviewer (as appropriate),
and follow the instructions provided.
To retrieve your username and password, click “Forget your password?” on the Editorial
Manager log-in page.
If you have questions or experience problems uploading your manuscript or review,
please contact the editorial ofﬁce:
Telephone: 215-762-1854
E-mail: jtcvs@drexelmed.edue 2007
Borger et al Surgery for Acquired Cardiovascular Disease
A
CDFigure E1. Survival (SEM) after MV repair for IMR in patients undergoing annuloplasty alone (control) versus
annuloplasty plus division of secondary chords (chordal cutting). MV, Mitral valve; IMR, ischemic mitral
regurgitation.
Figure E2. Event-free survival (SEM) in patients undergoing annuloplasty alone (control) versus annuloplasty
plus division of secondary chords (chordal cutting). Event-free survival was defined as freedom from death,
recurrent moderate or more MR, reoperation, thromboembolism, hemolysis, major hemorrhage, or endocarditis.
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